RxDoctor Payments Data

Elias Martinez, MD

General Practice · Gainesville, FLNPI 1346342656

Payments from drug & device makers

$2,862in general payments, 2019–2025

Across 173 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$743
  • Novo Nordisk$665
  • Lilly USA, LLC$664
  • GSK$203
  • Merck$109
  • Exact Sciences$88
  • plus $389 from 12 others

What the payments were for

  • Food & beverage$2,862100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,862 in reported general payments places this provider in the 90th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$21,851
Medicare patients
66
Services billed
274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin36$41,995
OzempicSemaglutide34$40,689
EliquisApixaban25$28,191
PrezcobixDarunavir/Cobicistat11$26,521
TivicayDolutegravir Sodium11$24,335
JanuviaSitagliptin Phosphate18$24,006
FarxigaDapagliflozin Propanediol17$22,339
XareltoRivaroxaban20$21,807
SymbicortBudesonide/Formoterol Fumarate41$10,944
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,100
Celecoxib147$4,826
Novolog Mix 70-30Insulin Aspart Prot/Insuln Asp19$3,189
Albuterol Sulfate HfaAlbuterol Sulfate91$2,455
SynthroidLevothyroxine Sodium18$2,251
Levothyroxine Sodium162$1,498

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonPrezcobix, Xarelto$15$48,32831 claims
Novo NordiskOzempic, Novolog Mix 70-30$665$43,87853 claims
Boehringer IngelheimJardiance$71$41,99536 claims
AstraZenecaFarxiga, Symbicort$743$33,28358 claims
PfizerEliquis$34$28,19125 claims
MerckJanuvia$109$24,00618 claims
GSKTrelegy Ellipta$203$8,10012 claims
AbbVieSynthroid$73$2,25118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,901 general practice providers in Florida.

Other general practice in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →